To support clinical applications, GENEWIZ has established next generation sequencing and Sanger-based CLIA-compliant workflows ensuring high-quality laboratory testing for accurate and consistent sequencing results.
Our clinical lab is certified by The Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP) for providing clinical sequencing.
Features & Benefits
Superior data quality that exceeds manufacturer’s benchmarks
Industry-leading turnaround time delivers results when you need it
Ph.D.-level support during the entire project, including free consultations
Complementary NGS and Sanger services provide variant discovery-to-validation workflows
Clinical Next Generation Sequencing
GENEWIZ offers clinical NGS at two levels:
Research Use Only NGS in CLIA Environment
Sequencing performed in a CLIA-certified, CAP-accredited laboratory by CLIA-trained personnel on CLIA-qualified equipment. Recommended if data is used for research purposes only.
Our CLIA-validated assays provide the highest level of clinical regulatory compliance, including enhanced QA oversight and laboratory director signoff. Recommended if data is used for diagnostic purposes.
CLIA Environment | CLIA-Validated
Uncover mutations in coding and non-coding regions, including structural and copy number variants.